Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Precision Biosciences Inc (DTIL)  
$11.60 0.00 (0.00%) as of 4:30 Thu 2/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 110,820,000
Market Cap: 1.29(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2859 - $11.99
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Precision Biosciences is a clinical stage gene editing company focused on improving life by developing ex vivo allogeneic chimeric antigen receptor (CAR) T immunotherapies and in vivo therapies for genetic and infectious diseases with the application of its wholly owned proprietary ARCUS genome editing platform. Co. is simultaneously conducting a Phase 1/2a clinical trial evaluating PBCAR0191 as a potential first-in-class and a Phase 1 clinical trial evaluating PBCAR19B as, if approved, a potential CD19-targeting CAR T cell therapies in adult patients with relapsed or refractory, B-cell malignancies.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 90,000 189,021
Total Buy Value $0 $0 $43,200 $170,792
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 5
Total Shares Sold 0 349,251 362,612 450,033
Total Sell Value $0 $131,651 $141,672 $224,038
Total People Sold 0 4 4 4
Total Sell Transactions 0 6 7 12
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 156
  Page 1 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Smith J. Jefferson Chief Research Officer   •       –      –    2024-01-23 4 S $0.37 $10,360 D/D (28,000) 1,987,269 -3,078%     
   Scimeca Dario General Counsel and Secretary   •       –      –    2024-01-22 4 AS $0.36 $7,663 D/D (21,287) 151,028 3,019%     
   Amoroso Michael President and CEO   •       •      –    2024-01-22 4 AS $0.36 $49,460 D/D (137,390) 356,433 3,019%     
   List Alan Chief Medical Officer   •       –      –    2024-01-22 4 AS $0.36 $7,749 D/D (21,526) 94,982 3,019%     
   Scimeca Dario General Counsel and Secretary   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 59,345 172,315     -
   Amoroso Michael President and CEO   •       •      –    2024-01-20 4 OE $0.00 $0 D/D 266,720 493,823     -
   Smith J. Jefferson Chief Research Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 75,015 2,015,269     -
   List Alan Chief Medical Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 60,012 116,508     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 116,690 614,169     -
   Amoroso Michael President and CEO   •       •      –    2023-11-03 4 AS $0.40 $50,010 D/D (125,025) 227,103 2,626%     
   Scimeca Dario General Counsel and Secretary   •       –      –    2023-11-03 4 AS $0.40 $6,409 D/D (16,023) 112,970 2,626%     
   Amoroso Michael President and CEO   •       •      –    2023-11-02 4 OE $0.00 $0 D/D 283,390 352,128     -
   Scimeca Dario General Counsel and Secretary   •       –      –    2023-11-02 4 OE $0.00 $0 D/D 55,077 128,993     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2023-11-02 4 OE $0.00 $0 D/D 108,188 497,479     -
   Scimeca Dario General Counsel and Secretary   •       –      –    2023-08-31 4 A $0.39 $2,123 D/D 5,443 73,916     -
   Smith J. Jefferson Chief Research Officer   •       –      –    2023-08-31 4 A $0.39 $2,018 D/D 5,175 1,940,254     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2023-08-31 4 A $0.39 $2,321 D/D 5,951 389,291     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2023-08-18 4/A B $0.48 $43,200 D/D 90,000 383,340 2.74     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2023-08-18 4 A $0.48 $43,200 D/D 90,000 383,340     -
   Scimeca Dario General Counsel and Secretary   •       –      –    2023-06-08 4 AS $0.75 $10,021 D/D (13,361) 68,473 -59%     
   Barton Shane VP & Corporate Controller   •       –      –    2023-06-07 4 OE $0.00 $0 D/D 6,060 27,502     -
   Scimeca Dario General Counsel and Secretary   •       –      –    2023-06-07 4 OE $0.00 $0 D/D 31,771 81,834     -
   Kelly John Alexander Chief Financial Officer   •       –      –    2023-06-07 4 OE $0.00 $0 D/D 47,726 293,340     -
   Smith J. Jefferson Chief Research Officer   •       –      –    2023-06-07 4 OE $0.00 $0 D/D 4,872 1,935,079     -
   List Alan Chief Medical Officer   •       –      –    2023-04-27 4 AS $0.79 $6,139 D/D (7,771) 56,496 -46%     
  156 Records found
  1  2  3  4  5  6  7   
  Page 1 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us